NASDAQ Composite Index
23.365,69
PKT
+151,00
PKT
+0,65
%
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.12 | Altaba buy | Needham & Company, LLC | |
| 19.01.12 | Apple buy | Jefferies & Company Inc. | |
| 19.01.12 | BlackBerry sector perform | Scotia Capital Markets | |
| 19.01.12 | Check Point Software outperform | RBC Capital Markets | |
| 19.01.12 | Amazon outperform | RBC Capital Markets | |
| 19.01.12 | Apple outperform | RBC Capital Markets | |
| 19.01.12 | Amgen outperform | RBC Capital Markets | |
| 19.01.12 | Baidu.com buy | Nomura | |
| 19.01.12 | Apple overweight | Barclays Capital | |
| 19.01.12 | Baidu.com neutral | Credit Suisse Group | |
| 19.01.12 | Altaba buy | Stifel, Nicolaus & Co., Inc. | |
| 19.01.12 | Apple outperform | Robert W. Baird & Co. Incorporated | |
| 19.01.12 | BlackBerry hold | Jefferies & Company Inc. | |
| 19.01.12 | Alphabet A (ex Google) buy | Needham & Company, LLC | |
| 18.01.12 | Intel neutral | JP Morgan Chase & Co. | |
| 18.01.12 | Volvo (B) overweight | J.P. Morgan Cazenove | |
| 18.01.12 | eBay neutral | Nomura | |
| 18.01.12 | Apple overweight | Piper Jaffray & Co. | |
| 18.01.12 | Microsoft outperform | RBC Capital Markets | |
| 18.01.12 | NuVasive overweight | Barclays Capital | |
| 18.01.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 18.01.12 | Starbucks outperform | Williams Capital | |
| 18.01.12 | Alphabet A (ex Google) buy | Jefferies & Company Inc. | |
| 18.01.12 | Check Point Software buy | Needham & Company, LLC | |
| 17.01.12 | Infosys hold | Needham & Company, LLC | |
| 17.01.12 | Applied Materials outperform | RBC Capital Markets | |
| 17.01.12 | Royal Gold buy | UBS AG | |
| 16.01.12 | Volvo (B) neutral | Goldman Sachs Group Inc. | |
| 16.01.12 | Amazon overweight | JP Morgan Chase & Co. | |
| 13.01.12 | Akamai neutral | D.A. Davidson & Co. | |
| 13.01.12 | Apple overweight | Piper Jaffray & Co. | |
| 13.01.12 | Microsoft outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.01.12 | Biogen overweight | Barclays Capital | |
| 12.01.12 | ESCO Technologies neutral | Robert W. Baird & Co. Incorporated | |
| 12.01.12 | Cognex outperform | Robert W. Baird & Co. Incorporated | |
| 12.01.12 | Intel outperform | Credit Suisse Group | |
| 12.01.12 | Infosys sell | Société Générale Group S.A. (SG) | |
| 12.01.12 | Microsoft buy | UBS AG | |
| 12.01.12 | Apple buy | UBS AG | |
| 12.01.12 | Royal Gold sector perform | Scotia Capital Markets |